Tilray Brands, Inc. (TLRY)
Tilray Brands, Inc. (TLRY) Reports Q3 Loss, Beats Revenue Estimates
Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $1 per share a year ago.
Tilray Brands' Q3 Earnings on the Horizon: What's in The Offing?
TLRY heads into Q3 FY26 earnings with projected revenues up 10.9% and narrower losses, but margin pressure in cannabis and beverages clouds the outlook.
Tilray Brands, Inc. (TLRY) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $6.32, denoting a -3.36% move from the preceding trading day.
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
Tilray Brands, Inc. (TLRY) reached $6.54 at the closing of the latest trading day, reflecting a -5.76% change compared to its last close.
Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note
Tilray Brands, Inc. (TLRY) concluded the recent trading session at $6.95, signifying a -3.74% move from its prior day's close.
Tilray's Going To Be Great, But For Now It's A Hold
Tilray Brands, Inc. (TLRY) is expanding its international beverage business with the acquisition of UK-based Brew Dog and a partnership with Carlsberg. Management projects Brew Dog will generate $200M in annual net revenue by FY 2027, accelerating Tilray's UK market entry at low cost. Project 420 aims to drive profitability through SKU, geographic, and distributor rationalization, targeting synergy optimization by Q4 FY 2026.
Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today
Tilray Brands, Inc. (TLRY) reached $7.06 at the closing of the latest trading day, reflecting a -3.29% change compared to its last close.
Tilray Brands, Inc. (TLRY) M&A Call Transcript
Tilray Brands, Inc. (TLRY) M&A Call Transcript
Tilray Brands, Inc. (TLRY) Ascends While Market Falls: Some Facts to Note
Tilray Brands, Inc. (TLRY) reached $7.99 at the closing of the latest trading day, reflecting a +2.04% change compared to its last close.
Don't Even Think About Buying Tilray Stock Until You Read This Warning
Tilray has been expanding beyond marijuana to include hemp products and alcoholic beverages. The company's strategy has led to top-line growth, but it has yet to generate sustainable profits.
TLRY vs. CGC: Which Cannabis Stock is the Better Investment Now?
Tilray Brands' international revenue surge, beverage scale and strong cash position give it an edge over Canopy Growth as cannabis regulation and demand continue to evolve.
Tilray Has Already Done The Hard Part
Tilray is strategically positioned to benefit from U.S. cannabis reform, leveraging its diversified international and U.S. beverage operations. International medical cannabis, especially in Europe, drives TLRY's growth and margin stability, with Germany and Italy as key markets. Profitability hinges on sustained double-digit international growth, normalized interest and restructuring costs, and EBITDA consistently covering capital needs.
